Ingredient guide · Ingredient reference

Headache and migraine supplements: prevention evidence is limited and diagnosis matters

Magnesium, riboflavin, CoQ10 and feverfew have some evidence for migraine prevention, but the evidence is limited and they are not interchangeable rescue treatments. New or severe headache patterns need assessment before supplementation.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

A headache is not automatically migraine

NHS guidance distinguishes routine headaches from symptoms needing urgent care. A sudden extremely severe headache or headache with major neurological symptoms needs emergency assessment. Do not use a supplement trial to delay that evaluation. [1]

Prevention and relief of an attack are different goals

NCCIH describes limited evidence that magnesium, riboflavin, CoQ10 and feverfew may reduce migraine frequency. That does not establish immediate relief during an attack or a single best choice for every person. [2]

Safety can rule out a seemingly promising option

Butterbur has been studied, but serious liver-toxicity concerns led to withdrawal of a prior professional recommendation. A migraine product needs a safety review as well as an efficacy discussion, especially with pregnancy, other illnesses or medicines. [2]

Keep the formula and dose under review

The amount and preparation in research may differ from a retail blend. Avoid stacking several products without checking overlapping ingredients and interactions. The prevention plan should include an agreed outcome and review point rather than open-ended escalation. [3]

Track headache days and the treatment goal

Imagine someone wants fewer monthly migraine days. A diary can help discuss prevention options and response with a clinician. A product that feels relaxing after one dose has not thereby demonstrated migraine prevention or replaced the attack-treatment plan. [2][3]

Hypothetical example — match the goal to the evidence
Goal or findingMeaning
Sudden extreme headacheEmergency assessment
Fewer migraine daysPrevention outcome
Pain during an attackSeparate rescue-treatment decision
Headache and migraine supplements: prevention evidence is limited and diagnosis matters — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Headaches - NHS
    Source consulted: 2026-09-20. This is a reference resource, not a claim that we conducted the studies or tested a product.
  2. Headaches: What You Need To Know | NCCIH
    Source consulted: 2026-09-20. This is a reference resource, not a claim that we conducted the studies or tested a product.
  3. Dietary Supplements: What You Need to Know
    Source consulted: 2026-09-20. This is a reference resource, not a claim that we conducted the studies or tested a product.